SAN FRANCISCO--(EON: Enhanced Online News)--Providence Medical Technology, Inc. (PMT) announced market availability of its PMT Cervical Cage in the U.S. market. During the fourth quarter of 2013, the company will conduct a limited release of PMT Cervical Cage in preparation for a full release at the beginning of 2014.
“Our portfolio of minimally invasive devices offers significant clinical advantages for patients suffering from cervical radiculopathy.”
“We are excited to bring indirect decompression and fusion to the cervical market,” commented Jeff Smith, co-founder and Chief Executive Officer of Providence Medical Technology. “Our portfolio of minimally invasive devices offers significant clinical advantages for patients suffering from cervical radiculopathy.”
Providence will display a complete portfolio of cervical instruments and implants used in the treatment of cervical radiculopathy at the North American Spine Society (NASS) annual meeting held in New Orleans October 9-12. Interested parties can learn about PMT Cervical Cage, DTRAX Spinal System, DTRAX Graft, and PMT Bone Screws at booth #215.
“NASS represents a critical milestone in the history of Providence, as we will introduce U.S. surgeons to our novel, minimally invasive implants for the first time there,” continued Mr. Smith. “Our launch is already underway. We have trained our initial distributor partners and we will be holding cadaver surgeon training courses during the fourth quarter and throughout 2014.”
Providence Medical Technology is a privately held medical device company developing minimally invasive solutions addressing the $1 billion worldwide cervical fusion market. The company is commercializing the DTRAX platform of cervical devices, which are used to provide indirect decompression and fusion in patients suffering from cervical radiculopathy secondary to degenerative disc disease.